Comparison of the Dynamics of Resistance-Associated Mutations to Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, and Protease Inhibitors after Cessation of Antiretroviral Combination Therapy

Lignende værker

• Interruption of Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) Therapy for 2 Months Has No Effect on Levels of Human Immunodeficiency Virus Type 1 in Plasma of Patients Harboring Viruses with Mutations Associated with Resistance to NNRTIs
  af: Wirden, Marc, et al.
  Udgivet: (2003)
• Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana
  af: Moyo, Sikhulile, et al.
  Udgivet: (2019)
• Genotypic Inhibitory Quotient as Predictor of Virological Response to Ritonavir-Amprenavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients
  af: Marcelin, Anne-Geneviève, et al.
  Udgivet: (2003)
• Future of nonnucleoside reverse transcriptase inhibitors
  af: Sluis-Cremer, Nicolas
  Udgivet: (2018)
• A Novel Molecular Mechanism of Dual Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors
  af: Nikolenko, Galina N., et al.
  Udgivet: (2010)